ALBT stock icon

Avalon GloboCare
ALBT

$0.41
0.85%

Market Cap: 4.52M

 

About: Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment which is the key revenue driver; medical-related consulting services segment. It focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.

Employees: 6

0
Funds holding %
of 6,702 funds
Analysts bullish %
News positive %

Fund manager confidence

Based on 2024 Q1 SEC filings by fund managers ($100M+ AUM)

50% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 2

0.52% less ownership

Funds ownership: 1.42% [Q4 2023] → 0.91% (-0.52%) [Q1 2024]

23% less funds holding

Funds holding: 13 [Q4 2023] → 10 (-3) [Q1 2024]

58% less capital invested

Capital invested by funds: $75.8K [Q4 2023] → $31.9K (-$43.9K) [Q1 2024]

75% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 4

Research analyst outlook

We haven’t received any recent analyst ratings for ALBT.

Financial journalist opinion